Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 125
Assessing and Improving Value in Cancer Care: Workshop Summary Appendix A Workshop Agenda Assessing and Improving Value in Cancer Care A National Cancer Policy Forum Workshop Monday and Tuesday, February 9 and 10, 2009 NAS Lecture Room National Academy of Sciences Building 2100 C Street, NW Washington, DC DAY ONE 8:00 a.m. Welcome, Introductory Remarks: What Is Value in Cancer Care? Why Is It Important? Scott D. Ramsey, Fred Hutchinson Cancer Research Center 8:20 Physician–Patient Communication and Its Influence on Value Moderator: Allen S. Lichter, American Society of Clinical Oncology 8:25 Inside the Physician–Patient Discussion in Cancer Care Speaker: Anthony Back, University of Washington 8:55 Invited Comments from Diane Blum, CancerCare 9:00 Can We Communicate Effectively with Cancer Patients About the Benefits and Risks of Cancer Treatments? Speaker: Peter A. Ubel, University of Michigan
OCR for page 126
Assessing and Improving Value in Cancer Care: Workshop Summary 9:30 Invited Comments from Mary McCabe, Memorial Sloan-Kettering Cancer Survivorship Program 9:35 Therapy for Advanced-Stage Cancer: What Do Patients Want and Expect? Speaker: Robert Erwin, Marti Nelson Cancer Foundation 10:05 Invited Comments from Ellen Stovall, National Coalition for Cancer Survivorship 10:10 Discussion 10:40 10-Minute Break 10:50 Generating Evidence About Effectiveness and Value Moderator: Steven B. Cohen, Agency for Healthcare Research and Quality 10:55 FDA Perspectives on Evidence for Regulatory Approval in Cancer Speaker: Janet Woodcock, Food and Drug Administration 11:25 What Constitutes Reasonable Evidence of Efficacy and Effectiveness? Speaker: Daniel J. Sargent, Mayo Clinic 11:55 Discussion 12:25 p.m. Lunch 1:00 Value and the Oncology Market Moderator: Jeffrey C. Lerner, ECRI Institute 1:05 Drug Pricing and Value in Oncology vs. Other Areas in Medicine Speaker: Patricia M. Danzon, University of Pennsylvania 1:35 Industry Perspective on Pharmaceutical Pricing in Oncology Speaker: Greg Rossi, Genentech, Inc.
OCR for page 127
Assessing and Improving Value in Cancer Care: Workshop Summary 2:05 Cost Implications: Strategies to Enhance Value in Oncology Speaker: Deborah Schrag, Dana-Farber/Harvard Cancer Center 2:35 Discussion 3:20 10-Minute Break 3:30 Value in Cancer Practice: Health Insurer Perspectives Moderator: Scott D. Ramsey, Fred Hutchinson Cancer Research Center 3:35 Oncologists’ Perception of Value in Oncology Speaker: Peter J. Neumann, Tufts Medical Center 4:05 Paying for New Cancer Treatments: Rights and Responsibilities of Health Insurers Speaker: Lee Newcomer, United Healthcare 4:35 European Experience and Perspectives on Evaluating Value for Oncology Products Speaker: Michael Drummond, Centre for Health Economics, University of York 5:05 Discussion 5:50 Adjourned for the day DAY TWO 8:00 a.m. Ethical Issues for Value-Based Decision Making in Oncology Moderator: Harold L. Moses, Vanderbilt-Ingram Cancer Center 8:05 Ethical Issues When Considering Insurance Coverage Based on Value in the Treatment of Cancer Speaker: Dan W. Brock, Harvard Medical School
OCR for page 128
Assessing and Improving Value in Cancer Care: Workshop Summary 8:35 Patient–Physician Communication on Therapy Options for Cancer: Ethical Issues Speaker: Neil S. Wenger, University of California, Los Angeles 9:05 Discussion 9:35 10-Minute Break 9:45 Improving Value in Oncology Practice: Ways Forward Moderator: Lou Garrison, University of Washington 9:50 Value-Based Insurance Design—Initiatives Outside of Oncology Speaker: Michael Chernew, Harvard Medical School 10:20 Generating Evidence of Value Post-FDA Approval: Is There a Role for Health Insurers? Speaker: Sean R. Tunis, Center for Medical Technology Policy 10:50 Are There Ways to Improve the Value of Cancer Care That May Work at the Bedside? Speaker: Thomas J. Smith, Virginia Commonwealth University 11:20 Discussion WORKING LUNCH 12:05 p.m. Toward a Shared Understanding of Value: Can We Agree, and Does Perspective Matter? Moderator: Peter Bach, Memorial Sloan-Kettering Cancer Center Panel: All Moderators 1:30 Meeting Adjourned